Correction to“Inhaled Nanoparticles Accumulate at Sites of Vascular Disease”
Mark R. Miller(University of Edinburgh), Nicholas L. Mills(University of Edinburgh), Paul Fokkens(National Institute for Public Health and the Environment), A. John F. Boere(National Institute for Public Health and the Environment), Ken Donaldson(Royal College of Surgeons of Edinburgh), Colin J. Campbell, Flemming R. Cassee(Utrecht University), Jeremy P. Langrish, Rodger Duffin(Centre for Inflammation Research), Alex Vesey(University of Edinburgh), David E. Newby(University of Edinburgh), Jennifer Raftis, Petra Krystek(Deltares), Patrick W. F. Hadoke, Simon Wilson(Gosford Hospital), Pawitrabhorn Samutrtai(Chiang Mai University), Steven G. McLean, Shea P. Connell
Cited by 35
Related Papers
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy
|Particle and Fibre Toxicology|2005|2.1k
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration
|Biomaterials|2008|1.6k
Safe handling of nanotechnology
|Nature|2006|1.5k
Carbon Nanotubes: A Review of Their Properties in Relation to Pulmonary Toxicology and Workplace Safety
|Toxicological Sciences|2006|1.2k
Toxicology of nanoparticles: A historical perspective
|Nanotoxicology|2007|960